Ildong Pharmaceutical Co., Ltd. (KRX:249420)

Ildong Pharmaceutical Revenue

Ildong Pharmaceutical had revenue of 142.00B KRW in the quarter ending March 31, 2026, with 4.43% growth. This brings the company's revenue in the last twelve months to 572.95B, down -4.48% year-over-year. In the year 2025, Ildong Pharmaceutical had annual revenue of 566.93B, down -7.81%.

• Revenue (ttm): 572.95B
• Revenue Growth: -4.48%
• P/S Ratio: 1.08
• Revenue / Employee: 540.01M
• Employees: 1,061
• Market Cap: 620.71B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	566.93B	-48.01B	-7.81%
Dec 31, 2024	614.94B	14.18B	2.36%
Dec 31, 2023	600.76B	-36.96B	-5.80%
Dec 31, 2022	637.71B	77.58B	13.85%
Dec 31, 2021	560.13B	-1.71B	-0.30%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 3, 2026

Data Sources Report a data error